Treatt appoints SkinBioTherapeutics' Manprit Randhawa as interim CFO
(Alliance News) - Treatt PLC on Friday said it has appointed Manprit Randhawa as interim chief financial officer, effective from Monday. Read More
Price | 14.75p on 05-09-2025 | at 18:20:07
---|---|
Change | 0.00p 0% |
Buy | 15.00p |
Sell | 14.50p |
Last Trade: | Buy 125,000.00 at 15.00p |
Day's Volume: | 174,934 |
Last Close: | 14.75p |
Open: | 14.75p |
ISIN: | GB00BF33H870 |
Day's Range | 14.75p - 14.75p |
52wk Range: | 10.25p - 27.50p |
Market Capitalisation: | £38.17m |
VWAP: | 14.93412p |
Shares in Issue: | 258.78m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Skinbiotherap. (SBTX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 125,000 | 15.00p | Suspected BUY Trade |
16:39:31 - 05-Sep-25 |
Buy* | 125,000 | 15.00p | Ordinary |
16:37:44 - 05-Sep-25 |
Unknown* | -125,000 | 15.00p | Ordinary Correction |
16:37:44 - 05-Sep-25 |
Buy* | 645 | 14.88p | Ordinary |
15:14:34 - 05-Sep-25 |
Buy* | 2,852 | 14.78p | Ordinary |
13:41:11 - 05-Sep-25 |
Buy* | 6,847 | 14.78p | Ordinary |
11:48:20 - 05-Sep-25 |
Buy* | 22,765 | 14.78p | Ordinary |
10:58:05 - 05-Sep-25 |
Sell* | 6,396 | 14.515p | Ordinary |
10:27:10 - 05-Sep-25 |
Buy* | 66 | 15.00p | SI Trade |
08:28:26 - 05-Sep-25 |
Buy* | 333 | 15.00p | SI Trade |
08:28:26 - 05-Sep-25 |
Skinbiotherap. (SBTX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
14th Aug 2025 7:00 am | RNS | FY Trading Update |
30th Jun 2025 7:00 am | RNS | Croda Commercial Launch Progressing as Expected |
27th Jun 2025 7:00 am | RNS | Notice of IMC Shareholder Presentation |
25th Jun 2025 11:28 am | RNS | Holding(s) in Company |
20th Jun 2025 7:00 am | RNS | Result of WRAP Retail Offer |
16th Jun 2025 2:02 pm | RNS | WRAP Retail Offer |
16th Jun 2025 7:00 am | RNS | Superdrug agreement, Placing & Retail Offer |
22nd May 2025 12:44 pm | RNS | Correction: Change of Adviser |
22nd May 2025 7:00 am | RNS | Change of advisor |
9th May 2025 2:39 pm | RNS | Holding(s) in Company |